AWM
AVNS

Aevitas Wealth Management’s Avanos Medical AVNS Stock Holding History

Aevitas Wealth Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-87
Closed -$6K – 389
2018
Q3 		$6K Hold
87
– – 0.01% 377
2018
Q2 		$5K Hold
87
– – ﹤0.01% 366
2018
Q1 		$4K Hold
87
– – ﹤0.01% 374
2017
Q4 		$4K Buy
+87
New +$4K ﹤0.01% 376

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aevitas Wealth Management's AVNS Position: Q4 2018 in Review

Aevitas Wealth Management sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 87 shares — an estimated $6K sold.

Aevitas Wealth Management first reported a position in AVNS in Q4 2017 and held it in 4 quarters. The position peaked at $6K in Q3 2018. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • Aevitas Wealth Management reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • Aevitas Wealth Management sold 87 Avanos Medical shares in Q4 2018, an estimated $6K.
  • Aevitas Wealth Management first reported a position in Avanos Medical in Q4 2017 and held it in 4 quarters.
  • Aevitas Wealth Management's Avanos Medical position peaked at $6K in Q3 2018.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Aevitas Wealth Management's 13F filing for Q4 2018, filed 14 Feb 2019.